BRIEF published on 04/23/2025 at 09:10, 1 year 4 months ago BioNxt Solutions Advances in MS Treatment Study Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study
PRESS RELEASE published on 04/23/2025 at 09:05, 1 year 4 months ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS BioNxt Solutions Inc. reports advanced preparation for human bioequivalence study of BNT23001, a novel sublingual thin-film Cladribine formulation for Multiple Sclerosis treatment BioNxt Solutions Inc. Multiple Sclerosis Treatment Sublingual Thin-Film BNT23001 Human Bioequivalence Study
BRIEF published on 03/15/2025 at 00:05, 1 year 5 months ago BioNxt Solutions Closes Final Tranche of Convertible Debenture Offering Private Placement Convertible Debenture Warrants Financing BioNxt Solutions
PRESS RELEASE published on 03/15/2025 at 00:00, 1 year 5 months ago BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement BioNxt Solutions Inc. completes final tranche of convertible debenture Offering for $900,000. Funds to be used for product dev, IP, debt repayment, and working capital Private Placement Convertible Debenture Healthcare BioNxt Solutions Inc. Drug Delivery Technologies
BRIEF published on 03/01/2025 at 01:40, 1 year 6 months ago BioNxt Solutions Secures $1.6 Million in Convertible Debenture Private Placement Private Placement Convertible Debenture Investment BioNxt Solutions Proceeds Utilization
PRESS RELEASE published on 03/01/2025 at 01:35, 1 year 6 months ago BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement BioNxt Solutions Inc. closes first tranche of convertible debenture units Offering, raising $1.6M. Proceeds for product development, IP filings, debt repayment, and working capital Private Placement BioNxt Solutions Inc. Intellectual Property Product Development Convertible Debenture Units
BRIEF published on 02/24/2025 at 15:05, 1 year 6 months ago BioNxt Solutions Launches Debenture Unit Financing Private Placement Regulatory Approvals Convertible Securities Debenture Units Compensation Warrants
PRESS RELEASE published on 02/24/2025 at 15:00, 1 year 6 months ago BioNxt Solutions Announces Debenture Unit Financing BioNxt Solutions Inc. announces a non-brokered private placement of debenture units and Finders Warrants, expecting gross proceeds of up to $2,500,000, subject to regulatory approvals Private Placement BioNxt Solutions Inc. Regulatory Approvals Debenture Units Finders Warrants
BRIEF published on 02/22/2025 at 01:40, 1 year 6 months ago BioNxt Solutions Inc. Clarifies Promotional Activity Agreements Investor Relations German Market BioNxt Solutions Promotional Activities Option Plan
PRESS RELEASE published on 02/22/2025 at 01:35, 1 year 6 months ago Clarification of Promotional Activities BioNxt Solutions Inc. provides a clarification on engaging Apaton Finance GmbH and Cayo Ventures GmbH for investor relations services in Germany and Switzerland Investor Relations Services BioNxt Solutions Inc. Apaton Finance GmbH Cayo Ventures GmbH German Translations
Published on 09/10/2026 at 00:30, 21 minutes ago American Critical Minerals Announces Upsizing and Closing of Private Placement
Published on 09/10/2026 at 00:00, 51 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 09/09/2026 at 23:30, 1 hour 21 minutes ago Datametrex Announces Director Resignation and Appointment of Director
Published on 09/09/2026 at 23:30, 1 hour 21 minutes ago Core Critical Metals Corp. Announces Plan of Arrangement to Spin Out the Senneville and Timmins Nickel Projects
Published on 09/09/2026 at 22:45, 2 hours 6 minutes ago Algo Grande Copper Achieves BB Rating in First Digbee ESG Assessment at the Adelita Project
Published on 09/09/2026 at 19:14, 5 hours 37 minutes ago Sunbeth Global Concepts redeems ₦25.1bn Commercial Paper (CP), demonstrating strong liquidity, investor confidence
Published on 09/09/2026 at 18:26, 6 hours 25 minutes ago EQS-Adhoc: Vulcan Energy Resources Limited: Board succession and change to Chair role
Published on 09/09/2026 at 18:01, 6 hours 50 minutes ago MHM Corporate: Correction of the ORA 2 bond issuance amount
Published on 09/09/2026 at 18:00, 6 hours 51 minutes ago Porsche completes sale of its stakes in Bugatti Rimac and Rimac Group
Published on 09/09/2026 at 18:45, 6 hours 6 minutes ago Successful launch of a €500 million bond issue
Published on 09/09/2026 at 17:45, 7 hours 6 minutes ago Information concerning the total number of voting rights and shares 2026 08 31
Published on 09/09/2026 at 17:45, 7 hours 6 minutes ago Report on share repurchases from 7 to 8 September 2026
Published on 09/09/2026 at 17:45, 7 hours 6 minutes ago LANSON-BCC: H1 2026 results, A half-year marked by the integration of Champagne Heidsieck & C° Monopole
Published on 09/09/2026 at 17:40, 7 hours 11 minutes ago Neomat CAM plant: consortium in charge of civil engineering selected
